QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
NASDAQ:MDXH

MDxHealth (MDXH) Stock Forecast, Price & News

$2.28
-0.28 (-10.94%)
(As of 10/3/2023 ET)
Compare
Today's Range
$2.15
▼
$2.55
50-Day Range
$2.28
▼
$3.82
52-Week Range
$2.15
▼
$8.51
Volume
229,563 shs
Average Volume
168,283 shs
Market Capitalization
$61.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

MDxHealth MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
250.9% Upside
$8.00 Price Target
Short Interest
Healthy
0.21% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.25mentions of MDxHealth in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.44) to ($1.08) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars

Medical Sector

831st out of 966 stocks

Medical Laboratories Industry

20th out of 24 stocks

See Top Rated MarketRank™ Stocks Here

MDXH stock logo

About MDxHealth (NASDAQ:MDXH) Stock

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

MDXH Price History

MDXH Stock News Headlines

September 26, 2023 | finance.yahoo.com
Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer
August 29, 2023 | markets.businessinsider.com
BTIG Sticks to Its Buy Rating for MDxHealth S.A. Sponsored ADR (MDXH)
October 3, 2023 | Behind the Markets (Ad)
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
August 23, 2023 | finance.yahoo.com
MDxHealth Reports Q2 and Half Year 2023 Results
August 23, 2023 | finance.yahoo.com
MDxHealth SA Sponsored ADR (MDXH) Reports Q2 Loss, Tops Revenue Estimates
August 10, 2023 | tmcnet.com
Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth's Select mdx for Prostate Cancer Test
June 30, 2023 | finance.yahoo.com
MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting
June 16, 2023 | finance.yahoo.com
O6C0.MU - MDxHealth SA
October 3, 2023 | Behind the Markets (Ad)
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
June 6, 2023 | finanznachrichten.de
mdxhealth: MDxHealth Announces its Extraordinary General Shareholders' Meeting
June 2, 2023 | msn.com
MDxHealth (EBR:MDXH) Price Target Decreased by 21.55% to 0.99
May 23, 2023 | finance.yahoo.com
MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference
May 16, 2023 | marketwatch.com
2030, Oncology Precision Medicine Market Research
May 16, 2023 | msn.com
BTIG Maintains Buy Rating for MDxHealth: Here's What You Need To Know
May 16, 2023 | finanznachrichten.de
mdxhealth: MDxHealth Reports Q1-2023 Results
May 16, 2023 | markets.businessinsider.com
BTIG Reaffirms Their Buy Rating on MDxHealth S.A. Sponsored ADR (MDXH)
May 15, 2023 | finance.yahoo.com
MDxHealth SA Sponsored ADR (MDXH) Reports Q1 Loss, Tops Revenue Estimates
May 15, 2023 | finance.yahoo.com
MDxHealth Reports Q1-2023 Results
May 14, 2023 | markets.businessinsider.com
MDxHealth earnings preview: what Wall Street is expecting
May 12, 2023 | marketwatch.com
Globally Liquid Biopsy Products Market Growth Rate 2023
May 12, 2023 | msn.com
MDxHealth (EBR:MDXH) Price Target Decreased by 85.83% to 1.26
May 1, 2023 | finance.yahoo.com
MDxHealth to Present First Quarter 2023 Financial Results on May 15
April 28, 2023 | marketwatch.com
Global Liquid Biopsy Market by [2023-2029] with Revenue Outsourcing
April 25, 2023 | msn.com
Short Volatility Alert: Mdxhealth
April 24, 2023 | marketwatch.com
2023, The Metabolomic Platform Market is Expected to Witness a Substantial Rise in Revenue
April 19, 2023 | finance.yahoo.com
Foundational LCD Covers Select mdx for Prostate Cancer
April 19, 2023 | finance.yahoo.com
Earnings Preview: MDxHealth SA Sponsored ADR (MDXH) Q1 Earnings Expected to Decline
See More Headlines
Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

MDXH Company Calendar

Last Earnings
8/23/2023
Today
10/03/2023
Next Earnings (Estimated)
10/26/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MDXH
CUSIP
N/A
CIK
1872529
Web
mdxhealth.com
Phone
324-364-2070
Fax
N/A
Employees
252
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+258.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-44,040,000.00
Net Margins
-87.00%
Pretax Margin
N/A
Return on Equity
-203.05%
Return on Assets
-36.09%

Debt

Debt-to-Equity Ratio
1.45
Current Ratio
1.25
Quick Ratio
1.19

Sales & Book Value

Annual Sales
$37.05 million
Price / Sales
1.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
3.91

Miscellaneous

Outstanding Shares
27,040,000
Free Float
N/A
Market Cap
$60.30 million
Optionable
Not Optionable
Beta
0.30
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Michael K. McGarrity (Age 60)
    CEO & Exec. Director
    Comp: $571.37k
  • Mr. Ron Kalfus (Age 49)
    Chief Financial Officer
  • Mr. Joseph Sollee (Age 58)
    Exec. VP of Corp. Devel. & Gen. Counsel
  • Mr. John A. Bellano (Age 54)
    Chief Commercial Officer
  • Ms. Miriam Reyes (Age 50)
    Exec. VP of Operations
  • Dr. Wim Van Criekinge (Age 51)
    Chief Scientific Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













MDXH Stock - Frequently Asked Questions

Should I buy or sell MDxHealth stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MDXH shares.
View MDXH analyst ratings or view top-rated stocks.

What is MDxHealth's stock price forecast for 2023?

3 brokerages have issued twelve-month price objectives for MDxHealth's stock. Their MDXH share price forecasts range from $7.00 to $10.00. On average, they anticipate the company's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 258.7% from the stock's current price.
View analysts price targets for MDXH or view top-rated stocks among Wall Street analysts.

How have MDXH shares performed in 2023?

MDxHealth's stock was trading at $6.61 at the beginning of the year. Since then, MDXH shares have decreased by 66.3% and is now trading at $2.23.
View the best growth stocks for 2023 here.

Are investors shorting MDxHealth?

MDxHealth saw a increase in short interest in September. As of September 15th, there was short interest totaling 54,200 shares, an increase of 54.0% from the August 31st total of 35,200 shares. Based on an average trading volume of 79,000 shares, the short-interest ratio is presently 0.7 days. Currently, 0.2% of the company's stock are short sold.
View MDxHealth's Short Interest.

When is MDxHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our MDXH earnings forecast.

How were MDxHealth's earnings last quarter?

MDxHealth SA (NASDAQ:MDXH) posted its earnings results on Wednesday, August, 23rd. The company reported ($0.30) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.32) by $0.02. The company earned $16.75 million during the quarter, compared to analyst estimates of $15.14 million. MDxHealth had a negative net margin of 87.00% and a negative trailing twelve-month return on equity of 203.05%.

What guidance has MDxHealth issued on next quarter's earnings?

MDxHealth updated its FY 2023 earnings guidance on Thursday, August, 24th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $65.00 million-$70.00 million, compared to the consensus revenue estimate of $65.30 million.

When did MDxHealth IPO?

(MDXH) raised $45 million in an initial public offering on Thursday, November 4th 2021. The company issued 3,750,000 shares at $12.00 per share.

What is MDxHealth's stock symbol?

MDxHealth trades on the NASDAQ under the ticker symbol "MDXH."

How do I buy shares of MDxHealth?

Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MDxHealth's stock price today?

One share of MDXH stock can currently be purchased for approximately $2.23.

How much money does MDxHealth make?

MDxHealth (NASDAQ:MDXH) has a market capitalization of $60.30 million and generates $37.05 million in revenue each year. The company earns $-44,040,000.00 in net income (profit) each year or ($1.50) on an earnings per share basis.

How many employees does MDxHealth have?

The company employs 252 workers across the globe.

How can I contact MDxHealth?

MDxHealth's mailing address is CAP Business Center, Herstal, Liege 4040. The official website for the company is mdxhealth.com. The company can be reached via phone at 324-364-2070 or via email at ir@mdxhealth.com.

This page (NASDAQ:MDXH) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -